Product Images Arformoterol Tartrate
View Photos of Packaging, Labels & Appearance
- outercarton60 - 20250305111738
- outercarton30 - 20250305111923
- image 1 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 1
- image 2 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 2
- image 3 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 3
- image 4 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 4
- image 5 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 5
- image 6 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 6
- clinical figure 1 - clinical figure 1
- clinical figure 1 - clinical figure 2
- logo - ingenus logo
- structure - structure
Product Label Images
The following 12 images provide visual information about the product associated with Arformoterol Tartrate NDC 50742-395 by Ingenus Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
outercarton60 - 20250305111738
This is a description of Arformoterol Tartrate Inhalation Solution, which is a medication used for oral inhalation. The solution comes in sterile unit-dose vials with a potency of 15 meg per 2 mL. It is important to keep the solution refrigerated or store it at room temperature for up to 6 weeks. The solution is sensitive to light, excessive heat, and should be protected from these elements. It is advisable to use the medication as directed by a healthcare provider and not exceed the recommended dosage. Additionally, it is stressed to keep the solution out of reach of children. The manufacturer of this solution is Ingenus Pharmaceuticals, LLC, with an office location in Florida.*
outercarton30 - 20250305111923
This text provides information about Arformoterol Tartrate Inhalation Solution in 2 mL unit-dose vials. Each vial contains 15 mcg of arformoterol. It is for oral inhalation only and should be stored refrigerated or at room temperature for up to 6 weeks. The solution is light-sensitive and should be protected from excessive heat. The manufacturer is not mentioned, but the text indicates it is manufactured for "Genus Pharmaceuticals, LLC." The instructions advise storing unopened pouches in a refrigerator or at room temperature. It is important to follow the recommended dosage and expiration date. Additionally, the solution is not child-resistant, so it should be kept out of reach of children.*
image 1 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 1
image 2 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 2
image 3 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 3
image 4 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 4
image 5 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 5
image 6 - 27a1ba65 5029 462a 8e6e 5ac1056e6c72 119 6
clinical figure 1 - clinical figure 1
This text provides information on a study comparing the effect of 15 mcg arformoterol tartrate inhalation solution BID and a placebo on change from baseline FEV1 (Forced Expiratory Volume in 1 second) in individuals. The study was conducted with 143 participants in the placebo group and 141 participants in the arformoterol tartrate group. The baseline FEV1 value for the placebo group was 1.20 (L) while for the arformoterol tartrate group it was 1.15 (L).*
clinical figure 1 - clinical figure 2
This text provides data on the mean change from baseline Forced Expiratory Volume (FEV) in liters for two different treatments: placebo and 15 mcg arformoterol tartrate inhalation solution BID. It includes the number of participants in each group and their baseline FEV values.*
logo - ingenus logo
structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
